Sellas Life Sciences Group Inc (SLS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché SLS Giù? Forum Previsione Frazionamento azionario

Sellas Life Sciences Group Inc Azioni (SLS) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Cost Of Revenue	-	-	-	-	-
Selling, General, and Administrative	4.50% 2.867	3.002	2.858	2.481	2.967
Costs And Expenses	3.06% 7.083	6.873	6.063	6.918	7.329
Operating Income/Loss	3.06% -7.083	-6.873	-6.063	-6.918	-7.329
Nonoperating Income/Loss	7.35% 0.292	0.272	0.25	0.181	0.221
Income/Loss From Continuing Operations Before Tax	3.06% -7.083	-6.873	-6.063	-6.286	-7.329
Income/Loss From Continuing Operations After Tax	2.88% -6.791	-6.601	-5.813	-6.737	-7.108
Net Income/Loss	2.88% -6.791	-6.601	-5.813	-6.737	-7.108
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	9.98% 108.40	98.56	87.76	4.2618	68.25
Diluted Average Shares	9.98% 108.40	98.56	87.76	4.2618	68.25
Basic Earnings Per Share	14.29% -0.06	-0.07	-0.07	-0.08	-0.10
Diluted Earnings Per Share	14.29% -0.06	-0.07	-0.07	-0.08	-0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%